Press Release Contact

Press release:
Solaris Endovascular Receives FDA Breakthrough Device Designation for Solaris DE™, a new Drug-Eluting Covered Stent
May 05, 2026, 11:00 GMT

For questions about this press release, please contact the person or organization listed below.

Randy Hubbell
Solaris Endovascular, Inc.
+1 215-688-6196
Visit us on social media:
LinkedIn